Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Esophageal Squamous Cell Carcinoma × tislelizumab × Clear all

Phase

Status

Recruiting 9 Completed 6 Unknown 4 Not yet recruiting 2 Active not recruiting 2 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphatic Metastasis 1 Esophageal Squamous Cell Carcinoma 1

Interventions

camrelizumab 2 Radiotherapy 2 Paclitaxel 2 Cisplatin 2 Carboplatin 2 tislelizumab 1 pembrolizumab 1 nimotuzumab 1 atropine sulfate-diphenoxylate hydrochloride drug combination 1 Omeprazole 1 Loperamide 1 High-Energy Shock Waves 1 Gastroscopy 1 Drug Therapy 1 Dexamethasone 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06303583 2024-03-12

CRIS

Zhejiang Cancer Hospital

Phase 1/2 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡